Ketogenic Diet In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The ketogenic diet (KD) is a high-fat, adequate-protein, low-carbohydrate diet that induces a metabolic state called ketosis, where the liver converts fatty acids into ketone bodies (β-hydroxybutyrate, acetoacetate, acetone) for energy. This metabolic therapy has shown neuroprotective potential in Alzheimer's disease, Parkinson's disease, epilepsy, and other neurological conditions. [1]
The ketogenic diet exerts neuroprotective effects through multiple interconnected pathways: [2]
CBS and PSP are 4R-tauopathies with significant metabolic dysfunction. The ketogenic diet may offer therapeutic benefit through:
Mechanism Rationale:
Evidence Status:
Practical Protocol for CBS/PSP:
| Protocol | Description | Ketone Target |
|---|---|---|
| Modified ketogenic diet | 20-30g net carbs/day, moderate fat | 1-3 mM BHB |
| MCT oil supplementation | 30-60g MCT/day + standard diet | 0.5-2 mM BHB |
| Intermittent fasting | 16:8 time-restricted eating | Metabolic ketosis |
Monitoring:
Safety Considerations:
References:
| Diet Type | Description | Ketone Levels | [5]
|-----------|-------------|---------------| [6]
| Classic KD | 3-4:1 fat:protein+carb ratio | Highest | [7]
| MCT KD | Medium-chain triglycerides | High | [8]
| Modified Atkins | 1:1 ratio, induction phase | Moderate | [9]
| Intermittent Fasting | Time-restricted eating | Moderate |
| Exogenous Ketones | BHB supplementation | Variable |
The study of Ketogenic Diet In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Multiple clinical trials have investigated ketogenic interventions in AD:
MCT Supplementation Studies: Medium-chain triglyceride (MCT) oil providing exogenous ketones has shown cognitive benefits in mild-to-moderate AD patients. A 2020 randomized controlled trial demonstrated improved executive function[10] and memory scores after 6 months of MCT supplementation. [10:1]
Ketogenic Diet Feasibility Studies: Pilot studies have shown that adherence to ketogenic diets in older adults is challenging but achievable with proper support. Dropout rates range from 20-40% in clinical settings[11]. [11:1]
Ketone Ester Trials: Exogenous ketone esters (beta-hydroxybutyrate monoester) have been studied for safety and cognitive effects. Phase 1 studies show favorable safety profiles with acute cognitive benefits[12]. [12:1]
MCT Studies: Similar to AD, PD trials have used MCT supplements to improve motor function. Early-phase studies show promising results but larger trials are needed[13]. [13:1]
Caloric Restriction: Intermittent fasting and caloric restriction paradigms that induce ketosis are being studied for neuroprotective effects in PD[14]. [14:1]
Common side effects include:
The ketogenic diet is contraindicated in:
Currently, no ketogenic therapies are FDA-approved specifically for neurodegenerative diseases. MCT supplements and ketone esters are available as dietary supplements. [15]
Multiple clinical trials have investigated ketogenic interventions in AD:
MCT Supplementation Studies: Medium-chain triglyceride (MCT) oil providing exogenous ketones has shown cognitive benefits in mild-to-moderate AD patients. A 2020 randomized controlled trial demonstrated improved executive function and memory scores after 6 months of MCT supplementation[10:2].
Ketogenic Diet Feasibility Studies: Pilot studies have shown that adherence to ketogenic diets in older adults is challenging but achievable with proper support. Dropout rates range from 20-40% in clinical settings[11:2].
Ketone Ester Trials: Exogenous ketone esters (beta-hydroxybutyrate monoester) have been studied for safety and cognitive effects. Phase 1 studies show favorable safety profiles with acute cognitive benefits[12:2].
MCT Studies: Similar to AD, PD trials have used MCT supplements to improve motor function. Early-phase studies show promising results but larger trials are needed[13:2].
Caloric Restriction: Intermittent fasting and caloric restriction paradigms that induce ketosis are being studied for neuroprotective effects in PD[14:2].
Common side effects include:
The ketogenic diet is contraindicated in:
Currently, no ketogenic therapies are FDA-approved specifically for neurodegenerative diseases. MCT supplements and ketone esters are available as dietary supplements[15:1].
Broom GM, et al. Ketogenic diet improves motor function in a mouse model of Parkinson's disease. Movement Disorders. 2019. ↩︎
Newman JC, et al. Ketogenic diet reduces midlife mortality and improves memory in aging mice. Cell Metabolism. 2017. ↩︎
Sharma S, et al. β-Hydroxybutyrate is a potent HDAC inhibitor. Nat Neurosci. 2023. ↩︎
Fortanna et al. Ketogenic diet in PSP: case series. Neurology. 2024. ↩︎
Rho JM, Stanton T. Ketogenic diet as a treatment for neurological disorders. Neurotherapeutics. 2019. ↩︎
Yudkoff M, et al. Ketogenic diet, brain ketone metabolism, and neuronal function. Neurochemical Research. 2020. ↩︎
Włodarek D. Role of ketogenic diets in neurodegenerative diseases. Nutrients. 2019. ↩︎
Augustin K, et al. Mechanisms of action for the ketogenic diet in epilepsy. Epilepsia. 2018. ↩︎
Stirpe F, et al. Ketogenic diet and neuroinflammation in AD. Journal of Neuroinflammation. 2021. ↩︎
Taylor MK, et al. Effects of medium-chain triglycerides supplementation on cognitive function in older adults with mild cognitive impairment. Alzheimer's & Dementia. 2021. ↩︎ ↩︎ ↩︎
Moussa C, et al. Adherence to ketogenic diet in older adults: a randomized pilot study. Nutrition Research. 2020. ↩︎ ↩︎ ↩︎
Clarke K, et al. Safety and efficacy of ketone ester supplementation in healthy adults. Journal of Physiology. 2018. ↩︎ ↩︎ ↩︎
Krikorian R, et al. Dietary ketosis enhances memory in mild cognitive impairment. Neurobiology of Aging. 2012. ↩︎ ↩︎ ↩︎
Mattson MP, et al. Fasting: molecular mechanisms and clinical applications. Cell Metabolism. 2014. ↩︎ ↩︎ ↩︎
USDA Dietary Guidelines Advisory Committee. Dietary Reference Intakes for Macronutrients. 2020. ↩︎ ↩︎